The largest database of trusted experimental protocols

Pyrotinib

Manufactured by Selleck Chemicals
Sourced in United States

Pyrotinib is a chemical compound used in laboratory settings. It is a broad-spectrum kinase inhibitor that targets multiple receptor tyrosine kinases. Pyrotinib is employed in various research applications, including the study of cellular signaling pathways and the development of potential therapeutic agents.

Automatically generated - may contain errors

2 protocols using pyrotinib

1

Pyrotinib Sensitivity in ERBB2 Mutant NIH-3T3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse embryonic fibroblast cell line NIH‐3T3 was purchased from Cell Bank (Chinese Academy of Sciences, China). Cells were maintained in RPMI‐1640 medium (Invitrogen, Carlsbad, CA) supplemented with 1% penicillin plus streptomycin (HyClone, Logan, UT) and 10% fetal calf serum (Gibco BRL), and then incubated at 37℃ in a humidified incubator (5% CO2). Wild‐type and point mutation of ERBB2 were constructed into plasmids and transfected into cells with Lipofectamine 3000 reagent (Thermo Fisher, USA). After 36 h of transfection, cells were treated with Pyrotinib (200 nm) for additional 48 h. Pyrotinib (SHR‐1258) was purchased from Selleck.
+ Open protocol
+ Expand
2

Tarloxotinib and EGFR TKIs Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tarloxotinib and its activated drug, tarloxotinib-E, were provided by Rain Therapeutics Inc. We also used afatinib, poziotinib [second-generation (2G) EGFR TKIs], osimertinib [third-generation (3G) EGFR TKIs], and pyrotinib, which were purchased from Selleck Chemicals (Houston, TX, USA). Each drug was dissolved to a concentration of 10 mmol/L in dimethyl sulfoxide (DMSO, Sigma-Aldrich) and stored at −80 °C until use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!